How The Chang Robotics Fund Is Supporting OXOS

OXOS is breaking barriers in diagnostic access, and the Chang Robotics Fund is helping bring X-ray technology to the front lines of care.

At the Chang Robotics Fund, we back technologies that break down barriers, and OXOS is doing exactly that. Their mission is to expand access to diagnostic imaging by bringing portable, point-of-care X-rays to the front lines of healthcare. In both rural and urban settings, patients often face delays in diagnosis due to overburdened systems, outdated equipment, and a shortage of radiology staff. OXOS is changing all of that with their MC2 device.

This device is a compact, cordless X-ray system that fits in a travel case and can be set up in minutes. Designed for both clinical and non-traditional environments, OXOS technology allows front-line providers to capture high-quality images safely and efficiently at the point of need. It's not just about mobility; OXOS aims to enable faster decisions, reductions in radiation exposure, and improvements in care where it matters most.

The Chang Robotics Fund is excited to partner with OXOS to help make radiological imaging accessible to everyone. According to the World Health Organization, two-thirds of the world’s population has no access to radiological imaging. The one-third of the world that does have access must overcome high costs and logistical constraints. OXOS’ products solve a massive supply-side imbalance by making X-ray imaging accessible and safe for everyone.   

The Fund is extremely bullish on the market potential for OXOS. Given the global lack of access to X-ray imaging, medical use cases represent a blue-ocean growth strategy, including point-of-care imaging, last-mile care delivery, preventive care, and treatment discovery. Chang Robotics’ engineering team has also been partnering with OXOS to explore non-medical use cases for the Company’s portable imaging technology in industrial settings such as aerospace, consumer packaged goods, and infrastructure projects.  

Dr. Gregory Kolovich - Co-Founder and Chief Medical Officer

The market potential and broad-based impact of OXOS’ products are clear; however, it is their team that formed the backbone of our investment thesis. OXOS was founded by Evan Ruff, Chief Executive Officer, and Dr. Gregory Kolovich, Chief Medical Officer. Evan is a seasoned, successful entrepreneur, and Dr. Kolovich is a leading orthopedic hand surgeon who had the idea for OXOS due to frustrations with traditional X-ray imaging technology. The two co-founders have assembled a top-tier team with deep experience in scaling early-stage companies. The Fund is thrilled to partner with the OXOS team to help make X-ray imaging safe, accessible, and affordable to all.  

The Capital from the Chang Robotics Fund will support OXOS’s growth by increasing production capacity for its handheld X-ray systems, expanding into new market segments, and accelerating the development of next-generation innovations.

Evan Ruff - Co-Founder and Chief Executive Officer

"This investment will help us scale manufacturing and advance our imaging software capabilities. It positions us to meet growing demand while continuing to innovate around radiation dose reduction, image quality, and AI algorithms. With this funding, we can accelerate our roadmap—delivering portable, safe imaging systems that address the need for access to quality diagnostic imaging," says Evan Ruff, Co-Founder and CEO of OXOS

It's not too late to be part of the journey, but the clock is ticking! Join the Fund today to support cutting-edge technology like OXOS. Make sure to fill out our contact form to get in contact with our team. Exciting things are happening now!

To learn more about OXOS, visit www.oxos.com and follow OXOS on LinkedIn and Instagram. To get in contact, send OXOS an email at info@oxos.com.